Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Herpes simplex type-1 virus-based vectors for gene therapy].

T Ichikawa1, Y Saeki, T Tamiya

  • 1Department of Neurological Surgery, Okayama University Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reassessing the Management of Treatment-Induced Brain Necrosis in Metastatic Patients: Advancing Surgical Alternatives to Steroid Therapy.

Neurosurgery practice·2025
Same author

Gabapentinoids confer survival benefit in human glioblastoma.

Nature communications·2025
Same author

Leveraging next generation materials for cancer neuroscience therapies in the central nervous system.

Nature reviews. Materials·2024
Same author

The nuclear DICER-circular RNA complex drives the deregulation of the glioblastoma cell microRNAome.

Science advances·2020
Same author

The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.

Immunity·2017
Same author

In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.

Gene therapy·2015

Herpes simplex virus type 1 (HSV-1) vectors offer efficient gene transfer for gene therapy. Advances in HSV-1 vector systems, including replication-defective, conditional, and amplicon types, show promise for clinical applications.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Context:

  • Gene therapy leverages recombinant nucleic acid technologies and disease molecular biology.
  • Herpes simplex virus type 1 (HSV-1) possesses characteristics suitable for gene therapy vectors.

Purpose:

  • To review recent advancements in HSV-1-based vector systems.
  • To explore the applications of these vectors in gene therapy.

Summary:

  • HSV-1 vectors offer a wide host range, high gene transfer efficiency, and large transgene capacity due to gene deletions.
  • Unique properties include neuronal latency and oncolytic effects of specific mutants.
  • Three main vector types are discussed: replication-defective, replication-conditional, and amplicon vectors.

Related Experiment Videos

Impact:

  • HSV-1 vectors show potential for impacting clinical medicine through advanced gene therapy strategies.
  • Applications span various therapeutic areas, utilizing the virus's distinct biological features.